COLUMBUS, Ohio (WCMH) — Ohio lawmakers heard emotional testimony this week from several veterans, each describing how ...

The drug is currently classified as a Schedule I controlled substance in the United States, leading those seeking treatment ...

The FDA has accepted an investigational new drug application from a global biotechnology company for its investigational, ...

No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable market for SPC-15 worldwide SARASOTA, FL, July 07, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or ...

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery ...

Shares of Compass Pathways Plc (NASDAQ:CMPS) rose about 3% in premarket trading on Wednesday after the company said the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND ...

An experimental drug reverses PTSD-like symptoms in mice. The corresponding study was published in Signal Transduction and Targeted Therapy and may pave the way for a new treatment for PTSD. “This ...

MIAMI – The lack of progress in development of drugs to effectively treat posttraumatic stress disorder (PTSD) has become a "crisis" and has led to a significant shift in the US Department of Veterans ...

(RTTNews) - Silo Pharma, Inc. (SILO) has announced a partnership with medical device company Resyca BV to conduct a drug-device study supporting the FDA IND submission for its lead asset SPC-15, an ...

Researchers are discovering that post-traumatic stress disorder (PTSD) is a significant risk factor in developing dementia. Dementia is a memory problem that affects a person's ability to carry out ...

Tonix Pharmaceuticals’ experimental drug failed to treat fibromyalgia in a recent clinical study, causing the New York–based company to focus on developing the drug as a treatment for post-traumatic ...